National Institutes of Health (NIH)

No applicants.

The selection process and submission of this funding program are coordinated by the University of Arizona Cancer Center (UACC). For any other questions, please contact UACC Research Development (UACC-PreAward@arizona.edu)

The University of Arizona Cancer Center (UACC) can nominate one new (A0) application and one resubmission (A1) application for the NCI Research Specialist (Clinician Scientist) Award funding opportunityper receipt date.

Purpose of Award:

The UACC is seeking nominations for an National Cancer Institute (NCI) Research Specialist Award in any area of NCI-funded clinical cancer research. This FOA is specifically for clinician scientists to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees, and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. The Research Specialist Award is intended to provide stable support for clinician scientists at their institutions for significant leadership and exceptional participation in the NCI-sponsored clinical trials networks that conduct cancer treatment, prevention and control, and care delivery clinical trials. NCI-sponsored clinical trials networks include but are not limited to the National Clinical Trials Network (NCTN), the NCI Community Oncology Research Program (NCORP), the Experimental Therapeutics Clinical Trials Network (ETCTN), and the Cancer Prevention Clinical Trials Network (CP-CTNet).

The Research Specialist Award is designed to encourage the development of a career path for cancer clinical trial investigators who provide leadership, participation, and scientific support for the NCI clinical trials networks at their institutions and within those networks. This leadership includes the development of concepts and protocols for clinical trials, participation in scientific steering committees and network committees, and accrual to NCI-sponsored clinical trials. The institutional activities may include the implementation of cancer clinical trials including participation in the review of safety data, monitoring the conduct and progress of open clinical trials, and serving on institutional review committees. These activities are necessary for the successful conduct of NCI-sponsored cancer clinical trials. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others or other sources of funding for cancer research career continuity.

Applicant Eligibility

• Eligible applicants will be clinician scientists who have a clinical degree (M.D., D.O., D.D.S., D.M.D., O.D., D.C., PharmD., N.D., D.V.M.), possess active licensure, and are actively practicing in an oncology clinical setting.
• Individuals with a Ph.D. or other doctoral degree that have direct contact with patients or healthy subjects in clinical disciplines such as clinical psychology, nursing, clinical genetics, speech-language pathology, audiology, or rehabilitation are also eligible.

• At the time of application, the applicant cannot hold as a Principal Investigator current R01, P01, or other significant NIH funding (past funding does not affect eligibility). Support from P50 Career Development awards, R03, R21, P30 funding, or national network funding will be allowed, as long as the total NCI support does not exceed 6 person-months. Future substantial independent NIH funding will require the awardee to forfeit the R50.
• The applicant must be engaged in the conduct of NCI-funded cancer clinical trials research at an academic medical center and have a record of involvement in NCI-funded cancer clinical trial-related activities.
• At the time of application, the Research Specialist must have been at the institution for at least the previous two years.
• The Research Specialist must have a full-time position at the institution.
• The Research Specialist must commit 2.4 to 4.8 person-months to NCI-funded clinical activities during the life of the award. The Research Specialist may engage in other duties as part of the remaining 9.6 to 7.2 person-month effort not covered by this award. The maximum funded effort allowed on all NCI grants, including the R50, will be capped at 6 person-months.
• The Research Specialist must have demonstrated professional accomplishments consonant with his or her career status, and should have demonstrated cancer clinical research experience relevant to the NCI mission.

S. Mathena (Pediatrics)
One slot is still available.

UArizona may submit two proposals.

The NIH Director's Early Independence Award supports rigorous and promising junior investigators who wish to pursue independent research soon after completion of their terminal doctoral degree or post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations, are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Director's Early Independence Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Eligibility Requirements

Applications with multiple PDs/PIs will not be accepted. Only single PD/PI applications are allowed. Only the PD/PI may be listed as a Senior/Key Person and provide a Biographical Sketch.

U.S. citizenship is not required for PDs/PIs. For applications submitted on behalf of non-U.S. citizens with temporary U.S. visas, visa status must allow the PD/PI to conduct the proposed research at the applicant institution for the entire project period. The applicant institution is responsible for determining if and documenting that the PD's/PI's visa will allow the PD/PI to remain in the U.S. for the duration of the award.

Time window for eligibility: Given the focus on early research independence, the receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2022, and September 30, 2024. The degree receipt date is that which appears on the official transcript for the degree. The end of post-graduate clinical training includes residency and fellowship periods. The PD/PI must not have served as a post-doctoral fellow for more than 12 months following a previous, non-terminal doctoral degree (i.e., a post-doctoral fellowship served before June 1, 2022).

At the time of award, either 1) the Early Independence investigator must have received a PhD, MD, DO, DC, DDS, DVM, OD, DPM, ScD, EngD, DrPH, DNSc, ND (Doctor of Naturopathy), PharmD, DSW, PsyD, or equivalent doctoral degree from an accredited domestic or foreign institution (it is the responsibility of the sponsoring institution to determine if a foreign doctoral degree is equivalent), or 2) an authorized official of the degree-granting or training institution must certify that all degree requirements have been met and that the receipt date of the degree (as will appear on the transcript) will be before September 30, 2024.  An authorized official of the host institution must certify that the PD/PI will be able to conduct independent research at the institution at the time of the project start date.

Level of effort: In the first and second years of the project period, awardees must commit at least 9.6 person-months of effort to the Early Independence Award project each year (which is 80% effort per year). In years 3-5 of the project period, awardees may reduce their effort on the Early Independence Award project, but they must still conduct at least 9.6 person-months of general independent research each year (which is 80% effort per year). General independent research includes the effort spent on the Early Independence Award project and any other independent research projects the awardee is working on.

Research independence at time of application: Individuals are eligible only if they, at the time of application submission, do not have research independence. Lack of research independence is defined functionally rather than by position title. Eligible individuals must have all the following characteristics:

• The PD/PI's current research agenda is set through concurrence with mentors.
• The PD/PI's research is funded primarily through support to other investigators (mentored fellowships such as NIH F31 or F32 Fellowships or NSF Graduate Research Fellowships do not preclude eligibility).
• The PD/PI does not have any space assigned directly by the institution for the conduct of their research.
• The PD/PI, according to institutional policy, cannot apply for an NIH R01 grant without a special waiver or exemption from the institution.

Though PDs/PIs must not be functionally independent at the time of application submission, they may become functionally independent prior to time of award and still retain eligibility for the award.

Prospective PDs/PIs should contact appropriate institutional leaders to seek an appointment to an independent research position. Alternatively, institutions may actively recruit eligible junior scientists to apply for support through this program. In either case, the institution is expected to provide substantial support for the junior scientist, as detailed below. To foster independence, PDs/PIs may benefit from being hosted by an institution at which they have not previously studied or trained.

PDs/PIs may apply for a research career development (K) award and DP5 at the same time, but NIH policy prohibits scientific and commitment overlap. A PD/PI may not hold a DP5 and career development (K) award concurrently. If the PD/PI receives a career development (K) award, the career development (K) award must be relinquished to receive the DP5.

Limit: 1  // PI selected: 
V. Schaibley  (Cellular and Molecular Medicine)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The overarching goal of this NHGRI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.     

To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on  Curriculum Development. This NHGRI R25 program offers to support the development of curricula for Master of Science (M.S.) degree programs in genomics, genomic medicine and/or genomic informatics for medical students.

 Specifically, this FOA will support the development of curriculum designed to be freely available, at no cost to the broader community to enhance training in genomics for medical students.

S. Parthasarathy ( College of Medicine - of Pulmonary Allergy Critical Care and Sleep Medicine) 
 

The NIH Research Education Program (R25) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers. 

The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

The National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases, and sleep disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI expects efforts to diversify the workforce to lead to the recruitment of researchers from all groups, improve the quality of the educational and training environment, balance and broaden the perspective in setting research priorities, improve the ability to recruit subjects from diverse backgrounds into clinical research protocols, and improve the Nation's capacity to address and eliminate health disparities.

The overarching goal of this National Heart, Lung, and Blood Institute (NHLBI) R25 program is to support mentoring and research education activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. The major goal of this R25 program is to establish long-term mentoring that will enable junior faculty and transitioning postdoctoral students from diverse backgrounds, including those from groups that are underrepresented in the biomedical sciences (see, e.g., NOT-OD-20-031), to develop a research program and work with their home institution to obtain NIH funding. This FOA specifically invites applications that would support senior faculty, established researchers, and experienced mentors to develop and direct the Summer Institutes for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) in order to mentor promising eligible junior faculty and transitioning postdoctoral students from diverse backgrounds who have specific scientific interests in heart, lung, blood and sleep (HLBS) disorders research.

To accomplish the stated over-arching goal, this FOA will support educational activities with a primary focus on Research Experiences and Mentoring Activities (described below):

• Research Experiences for participating junior faculty and transitioning postdoctoral students from diverse backgrounds to enhance their research skills, experiences, and knowledge base relative to HLBS scientific areas and cross-cutting methodological approaches. This can include transitioning postdoctoral scientists who have received a formal full-time faculty appointment letter in hand and will have completed their postdoctoral appointment by the time the Summer Institute program to which they are recruited is convened.   

• Mentoring Activities by senior faculty, established researchers, and experienced mentors that include dedicated efforts to provide technical expertise, career advice, insight, and professional skills development opportunities to participating junior faculty and transitioning postdoctoral students from diverse backgrounds so that they can work with their institutions to compete for NIH grantss successfully.

Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L. Kirschstein National Research Service Award (NRSA) programs.

No applicants // Limit: 1 // Tickets Available: 1 

The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

• Courses for Skills Development: For example, courses and programs that use a team-based design approach which incorporates health equity, universal design (the purposeful design of products and environments to be useable by people of varying abilities and characteristics), design concepts early in educational activities, interaction between design students at different career/education levels, and state-of-the-art best practices (such as multidisciplinary/interdisciplinary education, the regulatory pathway and other issues related to the commercialization of medical devices), and further enhances these with novel creative and/or ground-breaking approaches and activities which will be implemented and evaluated with the goal of disseminating the outcomes for the benefit of the larger biomedical engineering education community. Programs may also include a clinical immersion experience that enhances skills and experiences in needs finding, communication across disciplines (including with healthcare providers, patients, caregivers, and/or communities), ideation coupled with frequent clinical/user feedback, and/or small projects to address minor, immediately solvable needs.
• NIBIB Statement of Interest: NIBIB interests include the development and integration of advanced bioengineering, sensing, imaging, and computational technologies for the improvement of human health and medical care. With this FOA, in addition to the goals described above NIBIB especially encourages courses and programs that incorporate the following topics: 1) Expanding the design perspective by designing for low resource settings; 2) Expanding the clinical immersion perspective by incorporating community-based engagement or emphasizing problem driven solutions; and, 3) Expanding the team perspective by including students from disciplines such as nursing, computer engineering, data science, and/or public health, as well as different education levels.

Applications are encouraged from institutions that propose to establish new or to enhance existing team-based design courses or programs in undergraduate biomedical engineering departments or other degree-granting programs with biomedical engineering tracks/minors. This FOA targets the education of undergraduate biomedical engineering/bioengineering students in a team-based environment. Health equity and universal design topics must be integrated throughout the educational activities. While current best practices such as multidisciplinary/interdisciplinary education, introduction to the regulatory pathway and other issues related to the commercialization of medical devices, and clinical immersion remain encouraged components of a strong BME program, this FOA also challenges institutions to propose other novel, innovative and/or ground-breaking activities that can form the basis of the next generation of biomedical engineering design education.

No applicants // Limit: 1 // Tickets Available: 1 

The overarching goals of the NIH R25 program are to: (1) complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs; (2) encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research; (3) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral and clinical sciences; and (4) foster a better understanding of biomedical, behavioral and clinical research and its implications. To accomplish the stated over-arching goals, this FOA will support creative educational activities with a primary focus on:

Research Experiences: The program needs to provide research experiences with the intention to extend the skills, experiences, and knowledge of genetic counselors. The program should provide experiences that allow the genetic counselors to enhance skills necessary to formulate and conduct genomic research independently and that is not available through other formal NIH training mechanisms. Research experiences should be in one or more of the areas relevant to NHGRI's research programs - genome sciences, genomic medicine, and ethical, legal, and social implicaions in genomics research.

M. Ramirez-Andreotta

UA may submit more than one application. 

There is no restriction on the number of applications an institution can submit to the SIG and/or High-End Instrumentation (HEI) Programs each year, provided the applications request different types of equipment. To prevent duplication of applications, this opportunity is Institutionally Coordinated by RII/UAHS.

The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-priced, specialized, commercially available instruments or integrated instrumentation system. The minimum award is $50,000. There is no maximum price limit for the instrument; however, the maximum award is $600,000. Instruments supported include, but are not limited to: X-ray diffractometers, mass spectrometers, nuclear magnetic resonance spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, flow cytometers, and biomedical imagers.

UA may submit more than one application.

There is no restriction on the number of applications an institution can submit to the SIG and/or High-End Instrumentation (HEI) Programs each year, provided the applications request different types of equipment. To prevent duplication of applications, this opportunity is Institutionally Coordinated by RII/UAHS.

The High-End Instrumentation (HEI) Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems. The minimum award is $600,001. There is no maximum price limit for the instrument; however, the maximum award is $2,000,000. Instruments supported include, but are not limited to, X-ray diffractometers, high throughput robotic screening systems, mass spectrometers, nuclear magnetic resonance spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, flow cytometers, and biomedical imagers.

UArizona may submit one application.

This opportunity is Institutionally Coordinated.

Institutional Ticket: J. Sweasy